Prosight Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-200,000
Closed -$10.2M 48
2025
Q2
$10.2M Sell
200,000
-143,326
-42% -$6.38M 2.48% 13
2025
Q1
$15.5M Sell
343,326
-107,801
-24% -$5.08M 5.08% 6
2024
Q4
$18.7M Sell
451,127
-14,698
-3% -$612K 5.23% 7
2024
Q3
$18.2M Buy
465,825
+151,025
+48% +$6.02M 4.61% 8
2024
Q2
$10.8M Sell
314,800
-150,200
-32% -$3.94M 3.22% 11
2024
Q1
$11.7M Buy
465,000
+171,699
+59% +$4.72M 3.25% 11
2023
Q4
$8.66M Sell
293,301
-60,207
-17% -$1.82M 3.6% 12
2023
Q3
$11.2M Sell
353,508
-321,492
-48% -$8.8M 3.54% 10
2023
Q2
$17.5M Buy
675,000
+107,174
+19% +$2.85M 5.11% 6
2023
Q1
$13.6M Buy
567,826
+259,050
+84% +$5.9M 6.53% 3
2022
Q4
$6.02M Buy
308,776
+23,776
+8% +$470K 3.37% 10
2022
Q3
$5.99M Buy
285,000
+123,473
+76% +$2.97M 3.29% 12
2022
Q2
$3.14M Buy
161,527
+87,597
+118% +$2.07M 2.55% 16
2022
Q1
$1.63M Buy
+73,930
New +$1.51M 1.15% 23
2021
Q1
Sell
-60,250
Closed -$1.05M 46
2020
Q4
$1.05M Buy
+60,250
New +$1.18M 0.53% 35

Other funds holding MIRM